TD Awareness Week is an opportunity to increase knowledge about tardive dyskinesia, an often misunderstood and stigmatized condition. Here are some ideas for advocacy. Tardive dyskinesia (TD) is an ...

Winona Tse, MD, Professor of Neurology at Icahn School of Medicine in New York City, discusses gendera, age, and psychiatric history as possible risk factors for the development of tardive dyskinesia.

Neurocrine Biosciences, maker of the first drug approved by the FDA to treat tardive dyskinesia, continues to throw its weight behind efforts to improve screening, monitoring and general awareness of ...

SAN DIEGO, May 6, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today renewed its commitment to increasing awareness and advancing care for people living with TD during Tardive ...

While 2017 saw the entrance of the first two drugs for tardive dyskinesia, the percentage of TD patients who are actually diagnosed remains in the single digits. Neurocrine is looking to change that ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. I think that the biggest challenges are, ...

- Mental Health Advocacy Community Recognizes and Over 40 States Declare First Week of May (2-8) Tardive Dyskinesia Awareness Week to Raise Awareness of this Burdensome and Often Misunderstood ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The state of Maryland is recognizing Tardive Dyskinesia (TD) Awareness Week, which runs May 1-7 this year. TD is a disorder that affects more than 600,000 Americans and is characterized by random, ...

For seven consecutive years, TD Awareness Week – which occurs each year during Mental Health Awareness Month – has brought together the mental health advocacy community and states across the country ...